top of page

Pharmaceutical firm partners psychobiotic startup for first foray into microbiome modulation

  • wendy0915
  • May 30, 2019
  • 1 min read

Updated: Dec 9, 2020

31-MAY-2019


 

Neuraxpharm Group, a pharmaceutical firm focused on the central nervous system (CNS), has announced its first foray in the probiotics category after signing a European distribution deal with startup firm Bened Biomedical Co.


From

Recent Posts

See All

Comments


©2024 by PS128.

bottom of page